Navigation Links
Sepsis Therapy in Preemies Fails to Boost Survival
Date:1/16/2009

Study suggests future treatments should focus on wider view of antibacterial defenses

FRIDAY, Jan. 16 (HealthDay News) -- Boosting the immune systems of premature babies with blood cell growth factor fails to prevent sepsis or improve survival rates, a new study shows.

Premature babies, especially those with lower than normal birth weight, tend to be prone to infections from low white blood cell counts. Blood growth factors, such as granulocyte-macrophage colony stimulating factor (GM-CSF), increase white blood cell counts and are often used in cancer patients to counter immune suppression caused by chemotherapy.

The London-based study, published in the current issue of The Lancet, found giving GM-CSF to premature babies with low birth weight did increase their white counts but, when compared with preterms who did not receive the treatment, they did not have lower rates of infection or better survival rates.

"We believe that, before embarking on future single-agent clinical trials, we should consider if this is too simplistic an approach to sepsis prevention in the preterm infant, whose immune system appears compromised in many different ways. ... Successful future stratagems will need a wider view of their antibacterial defenses," wrote the authors, lead by Robert Carr of Guy's and St Thomas Hospital NHS Trust in London.

More information

The U.S. National Library of Medicine has more about sepsis.



-- Kevin McKeever



SOURCE: The Lancet, news release, Jan. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
2. Educational Drive Cut Death Rate From Sepsis
3. Ashwell receptor reduces mortality during sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Research May Yield New Weapons Against Sepsis
6. Blacks More Likely to Die of Severe Sepsis
7. Scientists Probe Sepsis Deadly Secrets
8. Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
9. Hispanics Respond Poorly to Standard Hepatitis C Therapy
10. UNC study supports role of circadian clock in response to chemotherapy
11. North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sepsis Therapy in Preemies Fails to Boost Survival 
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology: